Sahajanand Medical Technologies IPO Shares List at ₹371.15 on NSE, 7.89% Premium

Sahajanand Medical Technologies Ltd. shares made their stock market debut on Friday, October 23, 2026, listing at ₹371.15 per share on the National Stock Exchange (NSE), representing a premium of 7.89% over the IPO issue price of ₹344 per share. On the Bombay Stock Exchange (BSE), the stock opened at ₹368.05, reflecting a listing premium of 6.99%.

The company's shares opened above the upper end of the IPO price band on both exchanges. The NSE listing price was ₹27.15 higher than the issue price, while the BSE listing price was ₹24.05 higher. Both exchanges recorded positive listing returns for investors allotted shares at the issue price.

The listing followed the company's ₹475.48 crore initial public offering, which opened for subscription on October 15, 2026, and closed on October 19, 2026. The issue received an overall subscription of 14.21 times, with the Qualified Institutional Buyers (QIB) category recording the highest subscription at 34.70 times. आयपीओची किंमत प्रति शेअर ₹327 ते ₹344 इतकी निश्चित करण्यात आली आहे.

Sahajanand Medical Technologies Limited is an India-based medical technology company specialising in the development, manufacturing and marketing of cardiovascular medical devices. Its product portfolio includes coronary stents, coronary balloons, transcatheter aortic valve implantation (TAVI) devices and other products used in vascular interventions.

Sahajanand Medical Technologies IPO Listing Details

Sahajanand Medical Technologies IPO was a ₹475.48 crore book-built issue comprising an offer for sale of approximately 1.38 crore equity shares. The IPO did not include a fresh issue component. Consequently, the company will not receive proceeds from the public offering, as the funds will go to the selling shareholders.

The IPO was priced in a band of ₹327 to ₹344 per share, with a minimum application lot of 43 equity shares. At the upper end of the price band, the minimum investment for an individual investor was ₹14,792.

पब्लिक इश्यू ऑक्टोबर 15, 2026 रोजी उघडण्यात आला आणि ऑक्टोबर 19, 2026 रोजी बंद झाला. The basis of allotment was scheduled for October 21, 2026, followed by the credit of shares to successful applicants' demat accounts on October 22, 2026.

The company also allotted approximately 40.71 lakh equity shares to anchor investors at ₹344 per share ahead of the public issue, raising ₹140.06 crore through the anchor portion.

On October 23, 2026, the shares debuted at ₹371.15 on NSE and ₹368.05 on BSE, representing listing premiums of 7.89% and 6.99%, respectively.

• जारी करण्याची किंमत : ₹344 प्रति शेअर

• NSE लिस्टिंग किंमत: ₹371.15 प्रति शेअर

• BSE लिस्टिंग किंमत: ₹368.05 प्रति शेअर

• NSE Listing Premium: 7.89%

• BSE Listing Premium: 6.99%

• Change From Issue Price at NSE Listing: +7.89%

• Change From Issue Price at BSE Listing: +6.99%

• एकूण सबस्क्रिप्शन: 14.21 वेळा

• इश्यू साईझ: ₹475.48 कोटी

• फ्रेश इश्यू: शून्य

• Offer for Sale: Approximately 1.38 crore equity shares

• प्राईस बँड : ₹327 ते ₹344 प्रति शेअर

• IPO उघडण्याची तारीख: ऑक्टोबर 15, 2026

• IPO बंद होण्याची तारीख: ऑक्टोबर 19, 2026

• लिस्टिंग तारीख: ऑक्टोबर 23, 2026

• एक्सचेंज: NSE आणि BSE

• NSE Trading Symbol: SMT

फर्स्ट-डे ट्रेडिंग परफॉर्मन्स

Sahajanand Medical Technologies share price began trading above their IPO issue price on both the NSE and BSE on October 23, 2026.

On the NSE, the shares opened at ₹371.15 compared with the issue price of ₹344, translating into a premium of ₹27.15 per share, or 7.89%.

On the BSE, shares opened at ₹368.05, representing a premium of ₹24.05 per share, or 6.99%. The difference between the two exchange opening prices was ₹3.10 per share.

For an investor allotted one lot of 43 shares at the issue price, the NSE listing price represented a gain of ₹1,167.45 on the allotment value of ₹14,792, before transaction costs and applicable taxes. At the BSE listing price, the corresponding gain was ₹1,034.15.

These figures represent returns at the respective exchange opening prices and do not account for subsequent intraday price movements.

सहजानंद मेडिकल टेक्नॉलॉजीज IPO सबस्क्रिप्शन स्थिती

The Sahajanand Medical Technologies IPO received an overall subscription of 14.21 times by the close of bidding on October 19, 2026.

QIB कॅटेगरीमध्ये 34.70 वेळा सर्वोच्च सबस्क्रिप्शन रेकॉर्ड केले, त्यानंतर NII कॅटेगरी 14.64 वेळा. वैयक्तिक गुंतवणूकदारांचा भाग 3.04 वेळा सबस्क्राईब करण्यात आला.

The subscription figures indicate that institutional participation accounted for the highest subscription multiple among the main investor categories. The company subsequently listed at a premium on both stock exchanges.

सहजानंद मेडिकल टेक्नॉलॉजीज लि. विषयी.

Sahajanand Medical Technologies Limited is a medical technology company headquartered in Surat, Gujarat. It manufactures and markets advanced medical devices used in cardiovascular and vascular treatments.

Its products include coronary stents, balloons, transcatheter aortic valve implantation devices, occluders, renal stents and peripheral drug-coated balloons. The company markets its products under flagship brands such as Supraflex Cruz, Cocoon and Hydra.

As of June 30, 2026, the company operated three manufacturing facilities across India and Thailand, with its products marketed across 77 countries. Its operations serve healthcare providers and medical institutions involved in cardiovascular procedures.